GC Cell Corporation
15 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 (NCT06341647) | GC Cell Corporation | 2024-10-31 |
| Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea (NCT06620510) | GC Cell Corporation | 2024-09-30 |
| Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis (NCT05258331) | GC Cell Corporation | 2021-10-25 |
| Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer (NCT04969731) | GC Cell Corporation | 2021-09-07 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation (NCT03983967) | GC Cell Corporation | 2019-01-24 |
| MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin (NCT03778619) | GC Cell Corporation | 2018-11-28 |
| Safety and Efficacy of "Immuncell-LC" in TACE Therapy (NCT02856815) | GC Cell Corporation | 2018-05-28 |
Track GC Cell Corporation automatically
Every clearance here is in the API, with alerts when new ones post.